šŸŽ Black Friday: 50% off Unlimited and 30% off Pro annual plans
Egetis Therapeutics AB (publ) (STO:EGTX)
Sweden flag Sweden Ā· Delayed Price Ā· Currency is SEK
11.12
0.00 (0.00%)
Nov 20, 2026, 5:29 PM CET

Egetis Therapeutics AB Stock Forecast

Stock Price Forecast

According to 4 analysts polled by S&P Global, Egetis Therapeutics AB stock has a consensus rating of "Hold" and an average price target of krĀ 11.21. The average 1-year stock price forecast is 0.81% higher than the current stock price, while the lowest is krĀ 4.30 (-61.33%) and the highest is krĀ 18.00 (+61.87%).

Price Target: krĀ 11.21 (+0.81%)
Analyst Consensus: Hold

Price Target

Chart
TargetLowAverageMedianHigh
PricekrĀ 4.30krĀ 11.21krĀ 11.28krĀ 18.00
Change-61.33%+0.81%+1.44%+61.87%

Analyst Ratings

The average analyst rating for Egetis Therapeutics AB stock is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.

Recommendation Trends

Chart
RatingJun '26Jul '26Aug '26Sep '26Oct '26Nov '26
Strong Buy333331
Buy000000
Hold000002
Sell000000
Strong Sell111111
Total444444

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
Cantor Fitzgerald
Cantor Fitzgerald
Hold
Downgrades
krĀ 33.00 → krĀ 11.25
HoldDowngradeskrĀ 33.00 → krĀ 11.25+1.17%Nov 5, 2026

Financial Forecast

Revenue This Year
537.63M
from 62.40M
Increased by 761.59%
Revenue Next Year
510.48M
from 537.63M
Decreased by -5.05%
EPS This Year
-0.76
from -0.90
EPS Next Year
-0.22
from -0.76
Fiscal YearFY 2021FY 2022FY 2023FY 2024FY 2025FY 2026E
Period EndingDec 31, 2021Dec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 2025Dec 31, 2026
Revenue
38.20M22.60M57.60M46.10M62.40M537.63M
Revenue Growth
-6.06%-40.84%154.87%-19.97%35.36%761.59%
Operating Income
-105.20M-197.00M-311.30M-321.80M-330.00M312.66M
Net Income
-104.50M-193.80M-326.90M-343.60M-342.50M315.98M
EPS
-----0.90-0.76
Free Cash Flow
-----268.50M567.45M
No. Analysts
-----4
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is SEK.

Revenue Forecast

Revenue202620272028
High965.0M
Avg537.6M
Low87.0M

Revenue Growth

Revenue Growth202620272028
High
1,446.5%
Avg
761.6%
Low
39.4%

EPS Forecast

EPS202620272028
High-0.76
Avg-0.76
Low-0.76

EPS Growth

EPS Growth202620272028
High-
Avg-
Low-